End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.
- Citation:
- J Clin Oncol vol 25 (29) 4569-74
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Other
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA25224
- Corr. Author:
- Authors:
- Daniel J Sargent Smitha Patiyil Greg Yothers Daniel G Haller Richard Gray Jacqueline Benedetti Marc Buyse Roberto Labianca Jean Francois Seitz Christopher J O'Callaghan Guido Francini Axel Grothey Michael O'Connell Paul J Catalano David Kerr Erin Green Harry S Wieand Richard M Goldberg Aimery de Gramont
- Networks:
- Study
- ACCENT
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords:
- Aged, Chemotherapy, Adjuvant, Clinical Trials, Phase III as Topic, Colonic Neoplasms, Colorectal Neoplasms, Data Interpretation, Statistical, Disease-Free Survival, Female, Humans, Male, Middle Aged, Proportional Hazards Models, Randomized Controlled Trials as Topic, Recurrence, Time Factors, Treatment Outcome